Type I IFN regulate DC turnover in vivo

European Journal of Immunology

Volumn 39, Issue 7, 2009, Pages 1807-1818

  Mattei, Fabrizio ^a   Bracci, Laura ^a   Tough, David F ^b,c   Belardelli, Filippo ^a   Schiavoni, Giovanna ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NIHR Biomedical Researcg Centre   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Apoptosis; DC; Turnover; Type I IFN

Indexed keywords

BROXURIDINE; CD11 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LIFESPAN; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SPLEEN; STEM CELL; SURVIVAL RATE; TURNOVER TIME; WILD TYPE;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD8; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE I; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN;

EID: 69249148680     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939233     Document Type: Article

References (52)

1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
2. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
3. Macagno, A., Napolitani, G., Lanzavecchia, A. and Sallusto, F., Duration, combination and timing: The signal integration model of dendritic cell activation. Trends Immunol. 2007. 28: 227-233.
4. Chen, M., Huang, L., Shabier, Z. and Wang, J., Regulation of the lifespan in dendritic cell subsets. Mol. Immunol. 2007. 44: 2558-2565.
5. Chen, M., Wang, Y. H., Wang, Y., Huang, L., Sandoval, H., Liu, Y. J. and Wang, J., Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006. 311: 1160-1164.
6. Matsue, H. and Takashima, A., Apoptosis in dendritic cell biology. J. Dermatol. Sci. 1999. 20: 159-171.
7. Ludewig, B., Krebs, P., Junt, T. and Bocharov, G., Dendritic cell homeostasis in the regulation of self-reactivity. Curr. Pharm. Des. 2003. 9: 221-231.
8. Opferman, J. T., Apoptosis in the development of the immune system. Cell Death Differ. 2008. 15: 234-242.
9. Hildeman, D., Jorgensen, T., Kappler, J. and Marrack, P., Apoptosis and the homeostatic control of immune responses. Curr. Opin. Immunol. 2007. 19: 516-521.
10. Hou, W. S. and Van Parijs, L., A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells. Nat. Immunol. 2004. 5: 583-589.
11. Nopora, A. and Brocker, T., Bcl-2 controls dendritic cell longevity in vivo. J. Immunol. 2002. 169: 3006-3014.
12. De Smedt, T., Pajak, B., Klaus, G. G., Noelle, R. J., Urbain, J., Leo, O. and Moser, M., Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J. Immunol. 1998. 161: 4476-4479.
13. De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P. and Urbain, J., Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 1996. 184: 1413-1424.
14. Gautier, E. L., Huby, T., Saint-Charles, F., Ouzilleau, B., Chapman, M. J. and Lesnik, P., Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. J. Immunol. 2008. 180: 6941-6946.
15. Kamath, A. T., Pooley, J., O'Keeffe, M. A., Vremec, D., Zhan, Y., Lew, A. M. and D'Amico, A., The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 2000. 165: 6762-6770.
16. Belardelli, F., Role of interferons and other cytokines in the regulation of the immune response. APMIS 1995. 103: 161-179.
17. Le Bon, A. and Tough, D. F., Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 2002. 14: 432-436.
18. Mattei, F., Schiavoni, G., Belardelli, F. and Tough, D. F., IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 2001. 167: 1179-1187.
19. Montoya, M., Schiavoni, G., Mattei, F., Gresser, I., Belardelli, F., Borrow, P. and Tough, D. F., Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002. 99: 3263-3271.
20. Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T. and Belardelli, F., Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000. 191: 1777-1788.
21. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D. F., Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001. 14: 461-470.
22. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. and Tough, D. F., Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 2003. 4: 1009-1015.
23. Lehner, M., Felzmann, T., Clodi, K. and Holter, W., Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells. Blood 2001. 98: 736-742.
24. Pokrovskaja, K., Panaretakis, T. and Grander, D., Alternative signaling pathways regulating type I interferon-induced apoptosis. J. Interferon Cytokine Res. 2005. 25: 799-810.
25. De Trez, C., Pajak, B., Brait, M., Glaichenhaus, N., Urbain, J., Moser, M., Lauvau, G. and Muraille, E., TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo. J. Immunol. 2005. 175: 839-846.
26. Tovey, M. G., Lallemand, C. and Thyphronitis, G., Adjuvant activity of type I interferons. Biol. Chem. 2008. 389: 541-545.
27. Kamath, A. T., Henri, S., Battye, F., Tough, D. F. and Shortman, K., Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002. 100: 1734-1741.
28. De Boer, R. J., Mohri, H., Ho, D. D. and Perelson, A. S., Estimating average cellular turnover from 5-bromo-2′-deoxyuridine (BrdU) measurements. Proc. Biol. Sci. 2003. 270: 849-858.
29. Sanchez-Sanchez, N., Riol-Blanco, L. and Rodriguez-Fernandez, J. L., The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 2006. 176: 5153-5159.
30. O'Keeffe, M., Hochrein, H., Vremec, D., Caminschi, I., Miller, J. L., Anders, E. M. and Wu, L., Mouse plasmacytoid cells: Long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8 (+) dendritic cells only after microbial stimulus. J. Exp. Med. 2002. 196: 1307-1319.
31. Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman, K., CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000. 164: 2978-2986.
32. Poast, J., Seidel, H. M., Hendricks, M. D., Haslam, J. A., Levy, H. B. and Baron, S., Poly I:CLC induction of the interferon system in mice: An initial study of four detection methods. J. Interferon Cytokine Res. 2002. 22: 1035-1040.
33. den Haan, J. M., Lehar, S. M. and Bevan, M. J., CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 2000. 192: 1685-1696.
34. Longman, R. S., Braun, D., Pellegrini, S., Rice, C. M., Darnell, R. B. and Albert, M. L., Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood 2007. 109: 1113-1122.
35. Kabashima, K., Banks, T. A., Ansel, K. M., Lu, T. T., Ware, C. F. and Cyster, J. G., Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005. 22: 439-450.
36. Foster, G. R., Masri, S. H., David, R., Jones, M., Datta, A., Lombardi, G., Runkell, L. et al., IFN-alpha subtypes differentially affect human T cell motility. J. Immunol. 2004. 173: 1663-1670.
37. Sevilla, N., McGavern, D. B., Teng, C., Kunz, S. and Oldstone, M. B., Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J. Clin. Invest. 2004. 113: 737-745.
38. Sandberg, K., Eloranta, M. L. and Campbell, I. L., Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. J. Virol. 1994. 68: 7358-7366.
39. Panaretakis, T., Pokrovskaja, K., Shoshan, M. C. and Grander, D., Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax. Oncogene 2003. 22: 4543-4556.
40. Meager, A., Visvalingam, K., Peterson, P., Moll, K., Murumagi, A., Krohn, K. and Eskelin, P., Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006. 3: E289.
41. Yarilina, A., DiCarlo, E. and Ivashkiv, L. B., Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J. Immunol. 2007. 178: 2204-2211.
42. Fujikado, N., Saijo, S., Yonezawa, T., Shimamori, K., Ishii, A., Sugai, S. and Kotaki, H., Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 2008. 14: 176-180.
43. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M. and Aguet, M., Functional role of type I and type II interferons in antiviral defense. Science 1994. 264: 1918-1921.
44. Tovey, M. G., Begon-Lours, J. and Gresser, I., A method for the large scale production of potent interferon preparations. Proc. Soc. Exp. Biol. Med. 1974. 146: 809-815.
45. Vremec, D., Zorbas, M., Scollay, R., Saunders, D. J., Ardavin, C. F., Wu, L. and Shortman, K., The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 1992. 176: 47-58.
46. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S. and Muramatsu, S., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
47. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.
48. Schiavoni, G., Mattei, F., Borghi, P., Sestili, P., Venditti, M., Morse, 3rd H. C., Belardelli, F. and Gabriele, L., ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 2004. 103: 2221-2228.
49. Lawry, J., Detection of apoptosis by the TUNEL assay. Methods Mol. Med. 2004. 88: 183-190.
50. Oberhaus, S. M., TUNEL and immunofluorescence double-labeling assay for apoptotic cells with specific antigen(s). Methods Mol. Biol. 2003. 218: 85-96.
51. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L. and Henson, P. M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 1992. 148: 2207-2216.
52. Livak, K. J. and Schmittgen, T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001. 25: 402-408.